Why LogicBio (LOGC) Stock Surged 13% In After-Hour Trading?
Shares of the clinical-stage genetic medicines company LogicBio Therapeutics Inc. (NASDAQ: LOGC) get traction in after-hours trading on Monday when it has gained 13.07% after the ring of the bell. However, during the normal trading, the stock has lost -6.02% to close the regular session at $7.96. Get the hottest stocks to trade every day […]
LogicBio Therapeutics, Inc. (LOGC) To Spend Proceeds of Public Offering To Strengthen Its Product Development Plans
LogicBio Therapeutics, Inc. (LOGC) is a biotechnology company dedicated to extend the scope of genetic medicine with pioneering targeted delivery platforms. The company recently closed the underwritten public offering of its common stock. The company offered 8.05 million shares of its common stock to the public at a per share price of $6.00. Included in […]
